Recruiting Follicular Lymphoma Studies in Louisville
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma....
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients...
About Follicular Lymphoma Clinical Trials in Louisville
Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.
There are currently 2 follicular lymphoma clinical trials recruiting participants in Louisville, KENTUCKY. These studies are seeking a combined 148 participants. Research is being sponsored by Giselle Sholler, Octapharma. Clinical trial participation is free and participants receive study-related medical care at no cost.
Follicular Lymphoma Clinical Trials in Louisville — FAQ
Are there follicular lymphoma clinical trials in Louisville?
Yes, there are 2 follicular lymphoma clinical trials currently recruiting in Louisville, KENTUCKY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Louisville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Louisville research site will contact you about next steps.
Are clinical trials in Louisville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Louisville studies also compensate for your time and travel.
What follicular lymphoma treatments are being tested?
The 2 active trials in Louisville are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov